Gastric dysmotility and visceral hypersensitivity – an ultrasound approach to functional GI disorders and diabetic gastroparesis by Steinsvik, Elisabeth Kjelsvik
Elisabeth Kjelsvik Steinsvik
Gastric dysmotility and visceral
hypersensitivity – an ultrasound
approach to functional GI
disorders and diabetic gastroparesis
2021
Thesis for the degree of Philosophiae Doctor (PhD)
University of Bergen, Norway
at the University of Bergen
Avhandling for graden philosophiae doctor (ph.d )
ved Universitetet i ergen
.
2017
Dato for disputas: 1111
Elisabeth Kjelsvik Steinsvik
Gastric dysmotility and visceral hypersensitivity
– an ultrasound approach to functional GI
disorders and diabetic gastroparesis
Thesis for the de ree of P il i  Doctor (PhD)
Date of defense: 24.09.2021
The material in this publication is covered by the provisions of the Copyright Act.
Print:     Skipnes Kommunikasjon / University of Bergen
© Copyright Elisabeth Kjelsvik Steinsvik
Name:        Elisabeth Kjelsvik Steinsvik
Title: Gastric dysmotility and visceral hypersensitivity – an ultrasound approach to functional GI
disorders and diabetic gastroparesis
Year:          2021
Scientific environment 
The National Centre for Ultrasound in Gastroenterology 
(NCUG) was established in 2001 at Haukeland University Hospital 
by the Norwegian Health Authorities. The aim of the centre is to 
improve ultrasound methods, develop new examination techniques 
and to stimulate to increased use of ultrasound in gastroenterology in Norway. NCUG 
was accredited as a European Learning Centre for ultrasound in 2014. This 
dissertation is number 26 on ultrasound-related subjects from NCUG. 
Bergen Research Group for Ultrasound in Gastroenterology 
(BRUSE) at Dept. of Clinical Medicine, University of Bergen focus 
on how ultrasound in clinical practice can improve management of 
patients with digestive diseases. A wide range of methodology has 
been developed and validated by BRUSE researchers, such as endosonography, three-
dimensional ultrasound, hydrosonography, strain rate imaging, contrast-enhanced 
ultrasound, sonoelastography, advanced visualization, and several novel techniques in 
GI motility. BRUSE is led by Professor Odd Helge Gilja. 
The National Centre of Competence in Functional 
Gastrointestinal Disorders at Haukeland University Hospital aims 
to share knowledge about clinical evaluation and treatment of 
patients with functional gastrointestinal disorders in Norway to 
health care providers and patients. Furthermore, the centre aims to 
improve diagnostic accuracy. The centre is led by Professor Jan Gunnar Hatlebakk. 
The work in this dissertation was funded by Helse 
Vest, and was performed at the Department of 
Medicine, Section for Gastroenterology, at Haukeland 





First, I want to thank my main supervisor Odd Helge Gilja. Thank you for believing 
in me, for giving me the opportunity to learn about ultrasound, and for letting me 
choose my own project in your group. Under your wings I have traveled the world 
and learnt so much! 
Trygve Hausken – my co-supervisor, and my friend! You have always been available 
for my questions, always interested, always kind. As a doctor you are a great example 
in how you always listen to the patients with kindness and enthusiasm. As a 
researcher, you are curious and always open for new ideas and projects, and I hope to 
follow in your footsteps.  
I am grateful for all input from the co-authors of my papers, in particular Jørgen 
Valeur, Dag André Sangnes and Eirik Søfteland. And many thanks to statistician Jürg 
Assmus for a fruitful and interesting collaboration on my third paper. Furthermore, I 
want to thank Hilde von Volkmann and Ingeborg Brønstad who worked with me on 
the healthy controls study. 
The ultrasound examinations included in this thesis have been performed at 
“Medisinsk Undersøkelse” at Haukeland University Hospital, with good help and 
goodwill from Roy Cato Solheim and the nursing staff, and not to forget Liv and 
Unni and other assistants who have made enormous amounts of “Toro klar 
kjøttsuppe” over the years! And thank you to Eirik and José for all the hours you have 
plotted data and helped with the database. 
A clinical study is impossible without participants – thank you to all colleagues who 
participated in the healthy controls study. And a humble thank you goes to all patients 
included in our studies. 
Birgitte Berentsen – we have been best friends from the day we first met. This 
journey would not have been half as fun without you. Thank you! Rannveig – thank 
you for all your wisdom, for helping me out with statistics in my first year, for yoga 
lessons together and good talks! Dear Ingrid, I have been blessed to walk this road 
 4
with you, thank you for support and love! My gratitude goes to Jan Gunnar 
Hatlebakk, no matter how busy your day has been, you have always had the time to 
help me when I have asked. And thank you to all my good friends in the Brain-Gut 
research group and in the Ultrasound group. 
I am blessed with a wonderful family who have supported me. Mamma – my mentor 
and cheerleader, thank you for all your support, philosophical talks, pizza, and 
lasagna, for teaching me about hard work and qualitative research! Pappa – thank you 
for being playful and loving the good things in life – for Kamel-rally, Settlers, cheese, 
wine, and home-made aioli! Marte – my sister and best friend, thank you for always 
being there for me and my family. It is good to know that I can always count on you. 
Thank you to Simon and Maria, Benjamin, Hans Fredrik and Helene for babysitting 
over the years, and for all the good times we’ve had together! Thank you to all my 
friends for being there even though we rarely meet these days. 
My “diamonds” Althea, Nikolai and Selda – life with you is never boring, I could not 
have asked for a better crew. I love you! 




2D-US Two-dimensional ultrasound 
3D-US Three-dimensional ultrasound 
5-HT Serotonin 
ANOVA Analysis of variance 
CI Confidence interval 
CLE Confocal laser endomicroscopy 
DG Diabetic gastroparesis 
EKS Elisabeth Kjelsvik Steinsvik 
EPQ-N Eysenck's Personality Questionnaire, Neuroticism scale 
EPS Epigastric pain syndrome 
FD Functional dyspepsia 
FGID Functional gastrointestinal disorder 
GE Gastric emptying 
GERD Gastroesophageal reflux disease 
GES Gastric emptying scintigraphy 
GI Gastrointestinal 
GIP Glucose-dependent insulinotropic polypeptide 
GLP-1 Glucagon like peptide 1 
IBS Irritable bowel syndrome 
IBS-C Irritable bowel syndrome, constipation type 
IBS-D Irritable bowel syndrome, diarrhoea type 
IBS-M Irritable bowel syndrome, mixed type 
IBS-SSS Irritable bowel syndrom symptom severity scale 
ICC Interstitial cells of Cajal 
IL Interleukin 
LME Linear Mixed Effects 
MC Mast cell 
MMC Migrating motor complex 
OHG Odd Helge Gilja 
 6
OR Odds ratio 
PDS Postprandial distress syndrome 
PI-IBS Post-infectious irritable bowel syndrome 
PPI Proton pump inhibitor 
PYY Peptide YY 
REK Regional ethical committee 
SCFA Short chain fatty acid 
T1D Type 1 diabetes 
T2D Type 2 diabetes 
TEER Transepithelial electrical resistance 
TH Trygve Hausken 
TNF-α Tumor necrosis factor alpha 
UMAT Ultrasound meal accommodation test 
VAS Visual analogue scale 





Functional dyspepsia (FD), irritable bowel syndrome (IBS) and diabetic gastroparesis 
(DG) are conditions with overlapping symptoms and motility characteristics. The 
objective of this dissertation was to investigate the link between gastric motility 
disturbances such as delayed gastric emptying and impaired accommodation, and 
symptoms from the upper gastrointestinal tract in these conditions. 
Material and methods 
To evaluate gastric function and upper gastrointestinal symptoms we examined 
patients with IBS and/or FD (n=248), diabetic patients with symptoms of 
gastroparesis (n=58) and healthy controls (n=30) with the ultrasound meal 
accommodation test (UMAT). Furthermore, patients with diabetes and symptoms of 
gastroparesis were examined with scintigraphy to evaluate gastric emptying. 
Results 
We found that patients with functional dyspepsia and diabetic gastroparesis had high 
levels of fasting and postprandial upper gastrointestinal symptoms and impaired 
gastric accommodation to a meal. All patient groups had antral distention in fasting 
state compared to healthy controls, and antral distention was correlated to delayed 
gastric emptying on scintigraphy. Furthermore, we found that the proximal gastric 
emptying rate in diabetic gastroparesis was reduced. There was weak or no 
association between ultrasound measurements and recorded symptoms. Patients with 
overlapping IBS and FD had severe symptom load but normal accommodation. 
Conclusion 
Gastric motor dysfunction is common in both functional gastrointestinal disorders 
and diabetic gastroparesis but cannot explain the observed symptoms. Ultrasound can 
be used to evaluate accommodation and emptying rate of the proximal stomach. 
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“Science and blood tests doesn’t say anything ‘bout how I feel” 
Highasakite, lyrics by Ingrid Helene Håvik 
 
Functional dyspepsia (FD), irritable bowel syndrome (IBS) and diabetic gastroparesis 
(DG) are conditions afflicting a large number of patients world-wide (1-3). A 
common denominator is disturbed motility of the gastrointestinal tract and altered 
visceral sensation. The patients also share many symptoms.  
Nausea, uncomfortable fullness, pain, and discomfort in the upper abdomen after a 
meal are unspecific and common symptoms. There are a multitude of possible causes, 
and we are often unable to explain with certainty why a patient experiences these 
symptoms. Some pathophysiological mechanisms are however associated with these 
dyspeptic symptoms, such as delayed gastric emptying, visceral hypersensitivity, 
impaired gastric accommodation and gastrointestinal dysmotility. In this thesis, we 
have explored the connection between symptoms and pathophysiology, mainly by use 
of ultrasound of the stomach and patient-reported symptom registrations. 
2.1 The normal stomach 
2.1.1 Stomach anatomy and structure 
The stomach has five regions: the cardia and gastroesophageal junction, the fundus, 
the corpus, the antrum, and the pylorus (Fig 1). It has two curvatures, the major and 
minor curvature. The primary electrical pacemaker of the stomach is located on the 
greater curvature, in the smooth muscle layer of the upper corpus. The vagus nerve is 





Figure 1: Normal anatomy of the stomach 
The stomach has three muscle layers, the outer oblique layer, the middle longitudinal 
layer, and the inner circular layer. The muscular layers of the stomach enable a 
coordinated propulsion of the stomach contents from the corpus and the antrum, to 
the pylorus. The pylorus remains closed until a wave of peristalsis occurs, whereupon 
the pylorus opens and allows appropriate portions of food to pass over to the 
duodenum. (4) Interstitial cells of Cajal (ICC) serve as pacemaker cells in the 
stomach and communicate with the enteric nervous system. Loss of ICCs are 
associated with gastric dysrhythmias (5, 6). 
 
2.1.2 The physiology and function of the stomach 
The stomach is an organ with several roles. It has a secretory function, secreting 
hydrochloric acid and pepsinogen, and gastrointestinal hormones such as 
somatostatin and ghrelin. Furthermore, it has a storage function, by decreasing wall 
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tone and thus increasing the gastric volume (gastric accommodation). And of great 
importance, it propulses the stomach contents distally, and this muscular activity both 
mixes and grinds the food and transfer it to the duodenum in due time (gastric 
emptying).  
 
Migrating motor complex 
The gastrointestinal tract is never inactive in a healthy human being. Between meals, 
there is still contractile activity, called the migrating motor complex (MMC). The 
MMC is recurring waves of peristalsis moving from the stomach to the terminal 
ileum in different strength during a cycle. One cycle lasts for 1.5-2h. The cycle starts 
with phase I, where only weak and infrequent movements occurs. In phase II, 
stronger phasic movements can be observed, and even “rumbling” noises from the 
stomach. This phase is associated with the sensation of hunger and is followed by 
phase III (fed state): contractions of the stomach, originating in the antrum and 
moving distally through the small bowel. Under normal conditions, 3 antral phase III 
contractions occur per minute, and they are always followed by, or occurring 
simultaneously with, duodenal phase III contractions. The phase III contractions are 
important to the interdigestive flow in the stomach and small intestine (7). 
The regulation of the MMC is complex, depending on several gastrointestinal 
hormones and neurotransmitters, and both autonomic and enteric nervous system 
stimuli.  
 
Gastric contractions during and after a meal 
The migrating motor complex in the stomach is interrupted when the stomach or 
duodenum is distended (8). When fluid or nutrients enter the small bowel, the MMC 
pattern is disturbed in all the small intestinal segments. After a while the MMC will 
restart, and the duration of the interruption of the cycles depends on the chemical 
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composition of the ingested meal. Lipids tend to give a longer disruption than e.g. 
glucose. (9) 
When we eat or drink, food and liquid enter the stomach. Water does not need any 
“treatment” by the stomach, and can pass directly on to the duodenum (10). The 
fundus and proximal corpus serve as a reservoir of the food, relaxing in order to 
increase the gastric volume (accommodation). The distal corpus and proximal antrum 
serve as a mixer, churning the food to small pieces (<2-3 mm) and mixing it with 
hydrochloric acid and pepsin. The result is a semi-liquid substance called chyme (11). 
Finally, the terminal antrum and pyloric sphincter serve as a filter for larger chunks of 
food, hindering them from passing into the duodenum, and as a grinder. When a large 
enough portion of chyme has entered the distal antrum, the antrum will contract 
forcefully simultaneously with a relaxation of the pylorus, and the portion of chyme 
passes over to the duodenum (antegrade jet). At the same time, some of the content is 
usually denied entrance, returning to even more churning in the antrum as a 
retrograde jet. (12) This can all be observed using high-frequency ultrasound (13-15).   
 
Gastric accommodation 
The fundus has mainly a relaxive role in response to eating. The process is called 
gastric accommodation and has several mediators. Receptive and adaptive relaxations 
are reflexes stimulated by stretching of mechanoreceptors in the oesophageal 
(receptive relaxation) or gastric (adaptive relaxation) wall, generating impulses 
carried by the afferent sensory neuron, in turn leading to the release of nitric oxide 
from the efferent neuron. The result is relaxation of the circular muscle layer of the 
stomach. In this way, the intragastric pressure decreases and the volume of the 
stomach increases in response to a meal (Fig.2) (16, 17). This was documented as 
early as in 1898 by Cannon in a x-ray study on cat (18), and demonstrated by 
Jahnberg in 1977 (19). The reflex was later found to be vagally mediated through 




Figure 2: Gastric accommodation of the proximal stomach in response to a 
meal. 
Mechanical stretching of the gastric wall is one important factor in triggering the 
accommodation reflex. However, evidence is emerging for other factors influencing 
the relaxation of the proximal stomach. Emotional and psychological stress may 
impair gastric accommodation, mainly through both activating cholinergic motor 
neurons. In an animal model, Miwa et al. showed that administrating a 5-HT2B 
receptor antagonist could reverse the negative effect of stress on accommodation, and 
that administration of a 5-HT2B receptor agonist could exacerbate the effect (26). In a 
later study, the same group demonstrated that negative effect exerted on gastric 
accommodation by stress could be reversed by administration of Acotiamide, a 
prokinetic drug facilitating acetylcholine release (27).  
Some papers have reported evidence toward gastric nutrient sensing affecting gastric 
accommodation, but this is a field requiring more research before conclusions can be 
drawn. In a human study from 2009, Vanden Berghe et al. showed that the 
accommodation reflex was triggered in both the oropharyngeal, gastric, and duodenal 
phase of digestion. They found that by inhibiting food from passing over to the 
duodenum, the participants still experienced an increase in satiety, indicating a degree 
of chemical sensing in the stomach. They found however that food reaching the 
duodenum was a much stronger stimulant on gastric accommodation (28). Some have 
suggested that the anticipation of food in itself can trigger the accommodation reflex, 
but this theory was not supported by Vanden Berghe’s study. 
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The duodenum seems to play a role in gastric relaxation as well. Lee et al. did a study 
where they infused 0.1N hydrochloric acid into the duodenum of 10 healthy subjects 
and observed a reaction of proximal gastric relaxation (29). This finding is supported 
by the results in Vanden Berghe’s study from 2009 (28). 
 
2.1.3 Regulatory hormones of the stomach 
Gastrin, somatostatin, and ghrelin, as well as regulatory peptides, are all produced by 
cells in the stomach. In addition, hormones produced in other parts of the 
gastrointestinal tract affect gastric secretions and motility, such as motilin, glucagon 
like peptide-1, cholecystokinin, serotonin, pancreatic polypeptide, and peptide YY 
(PYY) (9, 16, 30). Some of these hormones are involved in decreasing the 
postprandial glucose level and are called incretins. In the following, some hormones 
of importance for gastric motility will be addressed. 
 Ghrelin is an appetite increasing protein, produced in the endocrine cells in the 
stomach, as well as in the myenteric plexus (31). It signals through afferent vagal 
nerve fibres and crosses the blood-brain-barrier to bind to cells in the hypothalamus 
and increases appetite. The secretion of ghrelin is stimulated by adrenergic agents. In 
situations of negative energy balance, such as hypoglycaemia and fasting, the 
secretion increases. Conditions with energy excess, such as obesity and 
hyperglycaemia, and during meals, are associated with lower concentrations of 
ghrelin (9). 
Motilin is produced in the myenteric plexus (31) and by enteroendocrine cells 
in the duodenum and jejunum (32). Motilin can induce phase III contractions of the 
MMC and is associated with the sensation of hunger. The concentration of motilin 
fluctuates during the different phases of the migrating motor complex, with a peak 
concentration immediately before the phase III contractions occur (9). 
Glucagon like peptide 1 (GLP-1) is an incretin is produced by L-cells in the 
small and large intestine, and it stimulates insulin secretion and inhibits glucagon 
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secretion. It decreases hunger and influences gastric motility, delaying gastric 
emptying of solids and thus increasing the volume of the stomach both in fasting and 
postprandial conditions (33).  
Glucose-dependent insulinotropic polypeptide (GIP) is another incretin, 
secreted by endocrine cells in the small intestine. Release of GIP is stimulated by 
ingestion of glucose and other nutrients. Interestingly, the effect of GIP but not GLP-
1 is lost in diabetes type 2. It has an important role in obesity, enhancing clearance of 
triglycerides and stimulates lipid deposition in adipose tissues (34). 
 Gastrin has its effect on acid secretion in the stomach. The hormone is 
produced by G cells, mainly located in the antrum region of the stomach, and is 
secreted in response to meal intake. It has no direct effect on gastric accommodation 
or gastric emptying but may have an indirect effect through acid secretion and 
volume increase in the stomach (30). 
Pancreatic polypeptide is produced by F cells in the pancreas and is indirectly 
involved in the activity of the MMC by decreasing plasma levels of motilin (9). 
Peptide YY (PYY) reduces appetite and food intake in humans. It has a large 
span of physiological effects, both gastrointestinal and others. It delays gastric 
emptying and slows intestinal transit when nutrients reach the small bowel (30), 
inhibits gall bladder emptying and pancreatic secretions (35).  
Serotonin (5-HT) is a neurotransmitter present in the central nervous system, in 
blood platelets and in the gastrointestinal tract, where it is produced by 
enterochromaffin cells. Exogenous administration of serotonin increases phase III 
activity in all studied species. In humans, the effect on gastric and duodenal motility 
is mediated through 5-HT3-receptors. This is demonstrated with administration of the 
5-HT3 receptor antagonist ondansetron, which removes the gastric component of the 
phase III-contractions of the MMC by inhibiting the peaks in motilin (9, 36).  
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2.2 Using ultrasound to assess gastric function 
Ultrasound is a real-time technique. This means that the examiner can study 
physiological processes over time with high temporal resolution. In the field of 
gastroenterology, this is especially useful for assessment of the gastrointestinal tract. 
Ultrasound is used in assessment of the esophagus, stomach, small and large intestine 
(37, 38). In this thesis, the focus is on motility of the stomach. Ultrasound can be used 
to assess gastric volumes in both 2D and 3D, gastric emptying, and accommodation, 
antropyloric flow and antral contractility.  
2.2.1 Gastric accommodation measured with ultrasound 
As previously mentioned, the proximal stomach wall relaxes when we eat in the 
process called gastric accommodation. This dynamic process can be measured with 
the barostat, but ultrasound has proven to be a practical and non-invasive alternative 
(39, 40). The proximal stomach can be visualized with transabdominal ultrasound, 
using a standard curvilinear probe. 2D or 3D ultrasound can be used. If one chooses 
to use 2D ultrasound, a combination of sagittal and frontal sections is recommended 
(40).  
Many studies have been performed over the years using ultrasound to assess gastric 
accommodation. Gilja et al. administered glyceryl trinitrate to study the effect of 
nitrogen monoxide on gastric accommodation in a double-blind placebo-controlled 
cross-over study to patients with functional dyspepsia. They found impaired 
accommodation in FD that improved after administration of glyceryl trinitrate, as 
well as symptom improvement, showing the usefulness of the technique (41). Several 
studies have been performed later using ultrasound to assess gastric accommodation 
on different patient groups. In addition to multiple studies on functional dyspepsia 
(40, 42, 43), there are reports of studies on patients with diabetes (44, 45), reflux 
esophagitis (46), alcoholic liver cirrhosis (47) and in children with recurrent 
abdominal pain (48).  
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2.2.2 Volume estimation of the stomach and gastric emptying 
Ultrasound is a widespread method for estimating gastric emptying (GE) rates both in 
the clinic and in research. Although gastric emptying scintigraphy is still the golden 
standard for assessment of GE, ultrasound is often the method of choice because of 
the possibilities of real-time evaluation, its accessibility and the possibility of doing 
bedside examinations (49-53). Anaesthesiologists and surgeons evaluate the antrum 
as a Point-of-care ultrasound examination to assess gastric emptying and gastric 
contents both before and after surgery (54-56). Comparisons between ultrasound and 
gastric emptying scintigraphy have shown good agreement between the methods (50, 
57, 58).  
Figure 3: Ultrasound image of the antrum after ingesting a liquid meal. In 
this section, we find the antrum in close relation to the left liver lobe (L) and 
the aorta (A) and superior mesenteric vein (SMV) which are visible 
posterior to the antrum serving as internal landmarks.  
 
The most common method of estimating gastric emptying by ultrasound is to measure 
the antral area in a sagittal section (59). The antral area (Fig.3) is a measurement that 
has proved to correlate well with ingested volume (60). 
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Total gastric volumes and intragastric distribution of meals can be estimated using 
three dimensional ultrasound (3D-US) (61), and 3D-US is frequently used to evaluate 
gastric emptying (62-65). 
 
2.3 Functional dyspepsia 
Functional dyspepsia (FD) is one of the most common conditions under the umbrella 
“Disorders of Brain-Gut Interactions”. It is characterized by one or more of the 
following symptoms: 1) early satiety, 2) postprandial fullness, 3) epigastric pain or 4) 
epigastric burning. Other common explanations for the same symptoms, such as 
gastric ulcer, must be ruled out. Furthermore, the symptoms must be bothersome to 
the patient and impair normal activities. Patients frequently report other symptoms 
originating from the upper abdomen/chest, such as nausea, upper abdominal bloating, 
belching and heartburn. The patients are categorized by their symptoms into the 
following subgroups:1) Epigastric pain syndrome (EPS) and 2) Postprandial distress 
syndrome (PDS) or 3) overlapping EPS and PDS (Tab 2). EPS is associated with 
epigastric pain or burning, and not necessarily related to meals. PDS is characterized 
by meal-related dyspeptic symptoms. (66) 
The prevalence of FD is reported to be 10% (2, 67), but may be higher. In a 
population study from the USA, Pleyer et al. found that the number of people 
diagnosed with gastrointestinal reflux disease (GERD) has increased dramatically 
over the last years, while patient-reported symptoms of reflux have been relatively 
unchanged. At the same time, fewer patients have been diagnosed with functional 
dyspepsia. The authors suggest that GERD is a more widely known diagnosis, and 
that the substantial marketing of proton pump inhibitors (PPIs) has influenced how 
upper GI symptoms have been diagnosed. The fact that many GERD patients are not 
responding to PPI treatment may be explained by a faulty diagnosis (68). 
Patients with functional dyspepsia report reduced quality of life, and the diagnosis is 
associated with increased health care costs (2). 
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The hallmark symptoms of functional dyspepsia are early satiety, postprandial 
fullness and epigastric pain or discomfort. In a study from 2006, Karamanolis et al. 
found that 15 % of FD patients reported bloating as the predominant symptom, 10% 
reported nausea, 8% belching, 6% epigastric burning and 3% reported vomiting as 
their predominant symptoms. Postprandial fullness, epigastric pain and early satiety 
were reported as predominant symptoms in 24%, 22% and 12%, respectively (69). In 
addition, other co-existing conditions are common, such as anxiety, depression (70), 
migraine (71), fibromyalgia (72) and chronic fatigue syndrome (73, 74), or other 
functional gastrointestinal disorders. Both psychiatric and extraintestinal 
comorbidities seem to modulate FGID symptoms, and in some cases affect the 
quality of life to a greater degree than the FGID itself (75).  
 
2.3.1 The Rome criteria for Functional dyspepsia 
The clinical material of patients with functional dyspepsia and IBS in this thesis 
ranges from 1999 to 2014. During these years, there were two editions of diagnostic 
criteria for the functional gastrointestinal disorders; Rome II (76) and Rome III (77). 
The different criteria are summarized in Table 1, along with the current diagnostic 




Table 1: Historic and current diagnostic criteria for Functional Dyspepsia 
Rome II 1999 
At least 12 weeks, which need not be consecutive, within the preceding 12 months of:  
1. Persistent or recurrent dyspepsia (pain or discomfort centered in the upper abdomen); and 
2. No evidence of organic disease (including at upper endoscopy) that is likely to explain the 
symptoms; and  
3. No evidence that dyspepsia is exclusively relieved by defecation or associated with the onset 
of a change in stool frequency or stool form (i.e., not irritable bowel).(76) 
 
Rome III 2006 
Must include 
1. One or more of: 
a. Bothersome postprandial fullness  
b. Early satiation 
c. Epigastric pain  
d. Epigastric burning AND 
2. No evidence of structural disease (including at upper endoscopy) that is likely to explain the 
symptoms 
*Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis 
(77) 
 
Rome IV 2016 
1. One or more of the following:  
a. Bothersome postprandial fullness 
b. Bothersome early satiation  
c. Bothersome epigastric pain 
d. Bothersome epigastric burning  
2. No evidence of structural disease (including at upper endoscopy) that is likely to explain the 
symptoms. 
Must fulfill criteria for PDS and/or EPS. 
Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis.(66) 
 
 
The greatest difference between the Rome II and III criteria, was the introduction of 
the two subgroups, namely Postprandial Distress Syndrome (PDS) and Epigastric 
Pain Syndrome (EPS) (Table 2). The rationale for introducing two subgroups was the 
observed heterogeneity of the patient group, leading to a theory that functional 
dyspepsia may be indeed two distinct conditions with different aetiologies. This was 
supported by population-based studies (78, 79). Furthermore, symptoms as belching 
and nausea were classified as separate entities. However, clinical data has shown that 
there is a major overlap between the EPS and PDS, and patients also report symptoms 
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of postprandial nausea (80, 81). The two groups are very similar regarding gastric 
accommodation, gastric sensitivity and gastric emptying, and may not be as different 
from each other as originally assumed (82). The subgroups were continued in the 
Rome IV criteria, with minor alterations (66). 
Table 2: Epigastric Pain Syndrome and Postprandial Distress syndrome in 
the Rome III criteria 
Diagnostic Criteria* for Epigastric Pain 
Syndrome (EPS) 
Must include all of the following: 
1. Pain or burning localized to the 
epigastrium of at least moderate 
severity at least once per week 
2. The pain is intermittent 
3. Not generalized or localized to other 
abdominal or chest regions 
4. Not relieved by defecation or passage 
of flatus  
5. Not fulfilling criteria for gallbladder and 
sphincter of Oddi disorders 
 
Supportive criteria 
1. The pain may be of a burning quality but 
without a retrosternal component 
2. The pain is commonly induced or relieved by 
ingestion of a meal but may occur while fasting 
3. Postprandial distress syndrome may coexist 
 
Diagnostic Criteria* for Postprandial Distress 
Syndrome (PDS)  
Must include one or both of the following: 
1. Bothersome postprandial fullness, 
occurring after ordinary sized meals, at 
least several times per week 
2. Early satiation that prevents finishing a 




1. Upper abdominal bloating or 
postprandial nausea or excessive 
belching can be present 
2. 2. EPS may coexist 
 
 
*Criteria fulfilled for the last 3 months with symptom onset at least 6 months before diagnosis 
(77) 
 
In ICD-10, the diagnostic code system used by hospitals in Norway, there is no 
subclassification of functional dyspepsia. Thus, the patients in our material have not 
been classified as EPS or PDS.  
 
2.3.2 Pathophysiological mechanisms of FD 
Although some pieces of the puzzle are still missing, several abnormalities associated 
with functional dyspepsia are recognized. Gastric motor dysfunction is important, as 
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well as duodenal affection and brain-gut interactions. Based on what we know today, 
functional dyspepsia seems to be a multifactorial condition. 
Impaired gastric accommodation 
The normal accommodation reflex has been studied and documented for over 100 
years (18). But what happens if the proximal stomach does not relax as a response to 
a meal? The result is called impaired accommodation and is a common finding in 
functional dyspepsia and gastroparesis. The role of impaired accommodation in 
functional dyspepsia was first documented by ultrasound and scintigraphic studies by 
Gilja et al. and Troncon et al. (40, 83).  
When the proximal stomach fails to increase it volume sufficiently, the ingested food 
is forced to find its way further down to the distal part of the stomach, causing a 
distended antrum. This is thought to increase the symptom load. Tack et al. found in 
1998 that patients with impaired accommodation had more symptoms of early satiety 
and weight loss compared to patients with normal accommodation (84). However, the 
correlation between dyspeptic symptoms and the finding of impaired accommodation 
is not consistent in all studies (82, 85). 
The gold standard for evaluating gastric accommodation is the gastric barostat (86, 
87). The barostat consists of a gastric balloon adhered to a double lumen tube, 
connected to a barostat device, enabling subsequent expansion of the balloon. 
Allowing control over the volume and pressure in the balloon in the stomach, changes 
in the gastric pressure or volume can be registered. The barostat has been thoroughly 
validated and shows good results, but is invasive and uncomfortable for the patient, 
and time consuming (88). Other options for accommodation testing include single 
photon emission computed tomography (89), magnetic resonance imaging (90) and 




Delayed gastric emptying and antral dysmotility 
Another gastric motor disturbance associated with functional dyspepsia is delayed 
gastric emptying. Different studies report that 15-27% of patients with FD have 
delayed gastric emptying (82, 92, 93). Furthermore, Wilmer et al. found that patients 
with functional dyspepsia had a prolonged cycle length of MMC, a higher percentage 
of phase II contractions and lower percentage of phase III contractions compared to 
healthy controls (94). But although it is a common finding in patients with FD, these 
changes are often not correlated to the patient’s reported symptoms. However, a 
meta-analysis by Vijayvargiya and co-workers found strong correlations between 
several upper gastrointestinal symptoms and delayed gastric emptying in 
gastroparesis and functional dyspepsia (95). 
In addition to delayed gastric emptying and impaired accommodation, altered antral 
motoric function has been reported in functional dyspepsia, and the postprandial 
antral area was found to correlate to dyspeptic symptoms (96, 97).   
 
Duodenal barrier defect and low-grade inflammation 
Functional dyspepsia has traditionally been considered mainly a gastric disorder, but 
emerging evidence points toward the duodenum as a key region for instigating both 
symptoms and gastric motor alterations (98). The duodenum plays an important role 
through reflex and hormonal control of gastric emptying and accommodation in 
healthy individuals, and the effect of duodenal mucosal affection on the gastric motor 
function as well as upper GI symptoms has been the focus of many recent studies. 
Over the last decade, multiple research groups have shown that patients with 
functional dyspepsia have increased cell counts of eosinophils and mast cells 
indicating low-grade inflammation, and some have found this to correlate to 
dyspeptic symptoms. (99-101). Vanheel et al. also found low-grade inflammation, 
and furthermore demonstrated that patients with FD had impaired duodenal mucosal 
integrity, with reduced transepithelial electrical resistance (TEER), altered expression 
of several adhesion proteins, and increased paracellular passage (102). Nojkov et al. 
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examined 16 patients with functional dyspepsia and 18 healthy controls with upper 
endoscopy enhanced with duodenal confocal laser endomicroscopy (CLE), mucosal 
biopsies, and measured TEER. They found that patients with FD had higher epithelial 
gap density on CLE in the distal duodenum compared to healthy controls, and that 
they had impaired mucosal integrity. They also found changes in Claudin-1 and 
interleukin-6 expression. (103) Komori et al. found an altered mucosal barrier in 
patients with functional dyspepsia, with a lower zonula occludens-1 expression and 
higher interleukin-1β expression (104). Wauters et al. proposed in a review from 
2020 that the duodenum may be not only affected in functional dyspepsia, but may be 
the responsible for symptom generation and that the gastric motor abnormalities may 
be secondary to duodenal affection (105). However, this hypothesis has not yet been 
proven, and many questions remain unanswered.  
 
Visceral hypersensitivity 
Another factor of great importance for many (but not all) patients with functional 
dyspepsia is visceral hypersensitivity (69, 106). This can be measured in several 
ways, for example by balloon distention in the stomach by gastric barostat, or by 
drink tests (107). Patients with visceral hypersensitivity have a lower threshold for 
pain or discomfort compared to patients with normal sensitivity. This was not 
associated with changes in gastric accommodation or gastric emptying, implying that 
visceral hypersensitivity is a separate mechanism (106). In a multicentre study from 
2018, Simrén and co-workers demonstrated that visceral hypersensitivity is an 
important contributor to symptom generation in functional dyspepsia and irritable 
bowel syndrome, and that this effect remained after adjusting for psychological 
distress. This is important because it has been postulated that visceral hypersensitivity 
was merely an effect of hypervigilance due to anxiety/depression. (108). 
Early life adverse events are associated with increased risk of visceral 
hypersensitivity in adult life, and may furthermore give rise to epigenetic changes 
that can be passed on to the next generation (109). Sexual and physical abuse are 
other factors influencing visceral sensitivity. Van Oudenhove et al. found in a study 
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that a history of sexual abuse lowered the threshold for gastric discomfort, even when 
controlled for comorbid depression, somatization and sociodemographic factors 
(110).  
2.4 Irritable bowel syndrome 
Irritable bowel syndrome is, along with functional dyspepsia, one of the most 
common functional gastrointestinal disorders with a pooled global prevalence of 
11.2% (95% CI: 9.8 – 12.8%) (1). According to the current diagnostic guidelines 
(Rome IV), IBS is defined as a condition with recurring abdominal pain related to 
defecation or a change in bowel habits. Often there is a change in bowel habits (i.e. 
diarrhoea, constipation, or a mixed pattern) and/or symptoms of bloating or 
abdominal distention. Organic causes for the symptoms must be ruled out. (111) 
There are four subtypes of IBS, classified by the dominant bowel habit pattern: IBS 
with predominant diarrhoea (IBS-D), IBS with predominant constipation (IBS-C), 
IBS with a mixed bowel habit pattern (IBS-M), or patients with IBS where the bowel 
habits cannot be classified into one of the beforementioned groups (IBS-U 
(unclassified)).  It is estimated that approximately 1/3 of IBS patients have IBS-C and 
1/3 have IBS-D (112), but many patients report that their bowel habit pattern vary 
over time, making prevalence studies uncertain (113). 
Irritable bowel syndrome is a chronic condition, and currently there is no cure. 
However, many patients experience an improvement over time. Others report that the 
severity may fluctuate over time, typically increasing in periods of psychological 
stress. (114) 
 
2.4.1 Rome criteria in IBS 
Irritable bowel syndrome is acknowledged as a disorder of Gut-Brain interactions and 
diagnosed according to the Rome-criteria. Currently, the Rome IV criteria from 2016 
are used. In the papers concerning IBS in this thesis, the Rome II and III criteria were 
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used (Tab.3). The main differences between the Rome II and III criteria are based on 
the duration and frequency of the symptoms. In a report from 2009, Dorn and co-
workers showed that the two diagnostic criteria had high agreement and populations 
diagnosed with the two sets of criteria behaved similarly over time (115). In the 
Rome IV criteria discomfort was removed, excluding many patients and resulting in a 
lower prevalence (116). 
Table 3: Historic and current diagnostic criteria for IBS 
Rome II 1999 
At least 12 weeks, which need not be consecutive, in the preceding 12 months of abdominal 
discomfort or pain that has two of three features:  
1. Relieved with defecation; and/or  
2. Onset associated with a change in frequency of stool; and/or   
3. Onset associated with a change in form (appearance) of stool.(117) 
 
Rome III 2006 
Recurrent abdominal pain or discomfort** at least 3 days per month in the last 3 months 
associated with 2 or more of the following:  
1. Improvement with defecation  
2. Onset associated with a change in frequency of stool  
3. Onset associated with a change in form (appearance) of stool  
*Criteria fulfilled for the last 3 months with symptom onset at least 6 months prior to diagnosis. 
**Discomfort means an uncomfortable sensation not described as pain. (118) 
 
Rome IV 2016 (current) 
Recurrent abdominal pain, on average, at least 1 day per week in the last 3 months, associated 
with 2 or more of the following criteria:  
1. Related to defecation  
2. Associated with a change in frequency of stool 
3. Associated with a change in form (appearance) of stool 




2.4.2 Comorbidities and risk factors 
Some IBS patients report that they have had problems with abdominal pain since 
childhood. Others describe a gradual start, often associated with major life stress such 
as divorce or losing their job, and in many cases the symptoms start after a 
gastrointestinal infection. Because of the diverse start of symptoms, it can be 
challenging to design robust prospective epidemiological studies for assessing the 
risk factors for developing IBS. Another factor to consider, is how risk factors may 
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interact. It can sometimes difficult be certain what appeared first – the depression or 
the gastrointestinal symptoms? In a review from 2019, only including prospective 
population-based studies to eliminate some of these biases, Creed found that in 
western countries, female gender and young age were strong risk factors for 
developing IBS. Anxiety and depression were risk factors in all age groups. Stress, 
other pain conditions (such as fibromyalgia and migraine), sleep disorders and other 
functional gastrointestinal disorders were other risk factors. (119) 
 
2.4.3 Pathophysiological mechanisms of IBS 
Irritable bowel syndrome is a highly heterogeneous condition, perhaps consisting of 
different disease entities. The common denominator is abdominal pain related to 
bowel habits. The pathogenesis is multifactorial, and some important 
pathophysiological factors will be presented in the following. 
Post-infectious genesis 
The strongest risk factor for developing IBS is acute infectious gastroenteritis. The 
term post-infectious IBS (PI-IBS) is used about patients with symptoms of IBS that 
started in with an infectious gastroenteritis and has persisted for more than 6 months. 
The risk of developing PI-IBS is probably higher after a bacterial or protozoal 
gastroenteritis compared to viral ones. In a meta-analysis it was found that as many as 
10% of patients with enteritis later developed PI-IBS (120). Risk factors of particular 
importance are young age, female gender, psychological factors such as anxiety, 
depression, negative health beliefs, neuroticism and somatization, and the severity of 
the infection (121).  The first papers describing PI-IBS were published in 1950 by 
Stewart (122), and in 1962 by Chaudhary and Truelove (123). To date many different 
pathogens inducing the condition has been described. In Bergen, Norway, a large 
outbreak of water-borne giardia lamblia in 2004 resulted in 1262 subjects with 
laboratory-confirmed giardiasis. Many of these patients were subsequently included 
in the longitudinal Giardia-studies. In the 10 year follow-up study, as many as 43% 
(n=248) among 576 individuals who were exposed to Giardia in the 2004 outbreak 




Irritable bowel syndrome is not associated with severe inflammation, as we find in 
conditions such as ulcerative colitis or Crohn’s disease. However, a dysregulation of 
the immune system is frequently reported, as a sign of low-grade inflammation. 
Approximately 50% of IBS-patients have an increased activation of the immune 
system. Studies have shown increased infiltration of T-cells and mast cells (MCs) in 
the mucosa of the small and large intestine. In a meta-analysis, Bashashati et al. 
found that most of the included studies reported increased numbers of mast cells in 
biopsies from patients with IBS. In IBS-C there were only reports of increased MC 
counts in the descending colon, and in IBS-D there were increased cell counts in both 
rectosigmoid and descending colon (125). In IBS, and particularly PI-IBS and IBS-D,  
there have been demonstrated increased levels of MC mediators that have the ability 
to activate and potensate neurons, resulting in increased visceral pain perception and 
altered motor function (126). This can lead to pain and diarrhoea (126). Mast cells in 
the gut lining are situated in close proximity to GI mucosal sensory nerve fibres 
(127), and interactions between MCs and brain-gut neuronal networks are potentially 
part of the explanation of symptom perception in some IBS patients (126).  
Many studies have been performed on IBS populations to investigate the role of 
immune activation in symptom generation, and many studies have shown signs of 
increased inflammatory activity in IBS. Some have found increased eosinophil counts 
in colonic biopsies from IBS-patients, while others have found no difference 
compared to healthy controls (128). In a study on patients with self-reported food 
sensitivity, patients with IBS had higher interleukin-10 (IL-10) secretion from 
dendritic cells after lipopolysaccharide stimulation compared to healthy controls 
(129). Other studies have shown increased IL-6 and IL-8, and lower or normal 
expression of IL-10. Some have found elevated levels of tumour necrosis factor alpha 
(TNF-α) compared to normal. But in summary, results are conflicting and not 
convincingly unidirectional, and although the evidence indicate that low-grade 
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inflammation is important in the aetiology of IBS, the role of the immune system is 
still not fully elucidated.  
 
Intestinal permeability 
Multiple studies have shown an increased epithelial permeability in IBS, particularly 
in PI-IBS and in IBS-D. The epithelial barrier defects can be mediated by chronic and 
acute stress in two ways: 1) Via direct modulation of the permeability of the 
epithelium, or 2) by an increased translocation of gut microbes or microbe associated 
molecules such as lipopolysaccharides as a result of altered intestinal mucosa (130). 
 
 
Figure 4: Representation of the interplay between luminal and mucosal 
factors in functional gastrointestinal disorders. Food, microbiota, and bile 
acids from the intestinal lumen may permeate through the leaky epithelial 
barrier, affecting nerves and immune system and in turn affect sensory 
perception and intestinal physiology. 
Source: Barbara G et al. Gastroenterology 2016. Printed with permission. 
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Microbiota in IBS 
The microbiota is emerging as a major contributor to health and disease. Changes in 
microbiota composition is associated with a multitude of diseases and conditions, 
ranging from anxiety and depression to cardiovascular disease, diabetes, and 
inflammatory bowel disorders. Over the last decade it has become one of the major 
areas of research in the field of functional gastrointestinal disorders.  
The microbiota of the human gut is dominated by bacteria from the Bacteroidetes, 
Actinobacteria and Firmicutes phyla, and are found in greatest number in the colon 
(131). Many studies have been done on the IBS population, and results are somewhat 
conflicting. To date, it has not been possible to pinpoint one specific microbiota 
profile in IBS. However, some trends have been found. In a meta-analysis from 2019 
Wang and co-workers found that IBS patients had lower abundance of the commensal 
bacteria Lactobacilli and Bifidobacterium, and an overgrowth of the potential 
pathogens E. coli and Enterobacteriaceae (132).  
Several studies have shown that patients with comorbid IBS and anxiety/depression 
have a distinct microbial signature. In a meta-analysis Simpson et al. found that this 
patient group had a microbiota profile characterized by lower alpha diversity 
compared to patients with either disorder separately, and compared to healthy 
controls. Although different methods made direct comparisons difficult, a general 
finding was that the IBS + anxiety/depression group had a higher relative abundance 
of Proteobacteria and the genera Bacteroides and Prevotella, and lower abundance of 
the family Lachnospiracae.(133)  
Complex carbohydrates are often not fully digested in the small intestine, and pass on 
to the colon, where they are fermented by bacteria. The end products of bacterial 
carbohydrate fermentation are short chain fatty acids (SCFA), and they are important 
as fuel for our intestinal cells. Furthermore, SCFAs may work as signaling molecules, 
and in this way the bacteria in our bowels may communicate both locally and to the 
brain (131). SCFAs can even affect the inflammatory response of the innate immune 
system via different signaling pathways (134). 
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The composition and function of the microbiota is a field of research in growth. New 
methods are opening new possibilities, and it seems we are only in the beginning of 
understanding this immense field yet. Although we do not know the full significance 
of the microbiota in IBS, there is broad agreement that the bacteria, and maybe also 
fungi and viruses in our intestines, are of importance in IBS.  
 
2.5 Diabetic gastroparesis 
In Norway, estimated prevalence of type 1 diabetes (T1D) was 23.000 in 2020. Type 
2 diabetes (T2D), strongly associated to lifestyle and obesity, was more frequent with 
an estimated prevalence of 293,000 – 322,000, and approximately 60.000 of these 
cases were probably undiagnosed. (135)  
It is common knowledge that patients with long-lasting diabetes are at risk of 
developing complications. Peripheral neuropathy, retinopathy and nephropathy are 
common examples. Diabetes can affect almost all parts of the gastrointestinal tract, 
giving symptoms of nausea, fullness, abdominal pain, vomiting, constipation, and 
diarrhoea. In this thesis, we have included patients with diabetes and a medical 
history suggesting gastroparesis. 
Gastroparesis is a disorder of the upper GI tract defined by delayed gastric emptying 
(GE) without any mechanical obstruction of the gastric outlet (136). Diabetes is a 
common cause, and gastroparesis occurs in approximately 1-5% of diabetic patients 
(137, 138). In a population study from the USA, the prevalence of gastroparesis was 
calculated in a population of 43 million people. As type 2 diabetes is much more 
common than type 1 diabetes, type 2 diabetes represented 55.3% of the gastroparesis 
cases. But the risk of gastroparesis was markedly higher in patients with T1D 
(4.59%) compared to T2D (1.31%). Furthermore, women had higher risk of diabetic 
gastroparesis than men (62% of T1D and 63.5% of T2D were women) (138). It is 
estimated that approximately 5 million patients suffer from diabetic gastroparesis in 
the USA (139). 
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2.5.1 Clinical implications of gastroparesis 
The classical symptoms of gastroparesis are nausea, vomiting, bloating, postprandial 
fullness, and early satiety (136, 140), but upper abdominal pain is also frequently 
reported (141). The correlation between gastric emptying scintigraphy and patient 
reported symptoms is however varying in different studies. Some even find that rapid 
gastric emptying present with the same symptoms as delayed gastric emptying (142). 
Delayed gastric emptying have clinically important effects not only on the 
gastrointestinal symptoms for patients with diabetes. It also affects blood sugar 
control (Fig. 4).  
 
Figure 5: Diagram illustrating the complex connection between blood sugar 
regulation and gastric emptying in diabetic gastroparesis. 
 
GLP-1 is an incretin hormone that in addition to increasing insulin production and 
suppressing glucagon, slows gastric emptying (143). GLP-1 analogue treatment is an 
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option in T2D but is not a good choice for all patients. Some patients with type 2 
diabetes have rapid gastric emptying and may benefit from treatment with GLP-1 
analogues (144). Patients with gastroparesis will however risk an exacerbation of 
their delayed gastric emptying and are less likely to benefit from this medication. 
(139) 
Gastric emptying is traditionally assessed by gastric emptying scintigraphy (see 
methods section). Other methods are also available, including 13C labelled breath test, 
MRI, Wireless Motility Capsule (WMC) and gastric ultrasound. 
 
2.5.2 Pathophysiological mechanisms of diabetic gastroparesis 
Gastric emptying is a complex mechanism depending on input from both the 
autonomic and enteric nervous system, impulses from the interstitial cells of Cajal 
(ICCs), hormonal control, and is influenced by blood glucose levels. Multiple parts of 
the stomach can be contributing to delayed emptying. Antral hypomotility and 
impaired pyloric relaxation are important factors. Furthermore, impaired gastric 
accommodation and duodenal or small bowel dysmotility are involved in symptom 
generation in diabetic gastroparesis. 
 
Autonomic neuropathy 
Electrophysiology studies have shown multiple effects on the autonomic nervous 
system in diabetes. Slow wave contraction of the stomach, prolonged pyloric 
contractions and dyscoordination between the antrum and duodenum have all been 
demonstrated (145). Changes in vagal nerve fibres, both myelinated and 
unmyelinated, was demonstrated in patients with diabetic gastroparesis (146).  
Input from the vagus nerve is of great importance to sustain normal gastric 
accommodation. Patients with diabetes showed impaired accommodation (45, 140). 
Kumar and co-workers assessed gastric accommodation in patients with diabetic 
gastroparesis and found impaired accommodation in nine of 10 patients. However, 
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the accommodation did not correlate to the patient’s postprandial symptoms in this 
study (147).  
Enteric nervous system (ENS) and interstitial cells of Cajal (ICCs) 
The ENS is located in the intestinal wall, in the myenteric and submucosal plexi. 
Uniquely in the body, the enteric nervous system can function on its own, 
independent from central nervous system, but interacts with the autonomic nervous 
system (148).  
 
Figure 6 Pathophysiological changes in gastroparesis. Impaired 
accommodation of the proximal stomach, antral hypomotility and pyloric 
dysfunction are all physiological changes commonly seen in diabetic 
gastroparesis (DG). Loss or injury to Interstitial cells of Cajal (ICCs) is 
common in DG and is linked to macrophage activation in human and 
animal studies. Immune-mediated mechanisms probably play a critical role 
in the pathogenesis of DG. Courtesy of Grover et al, Gut 2019. Printed with 
permission (151) 
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The ENS is connected to the central nervous system, and sends signals via sensory 
neurons of stretch, pain, fullness, and nausea. Loss of enteric neurons, as well as loss 
of ICCs and smooth muscle disturbances, have all been described in human and 
animal studies of diabetic gastroparesis. The main mechanism of neuropathy is 
hypothesized to be via hyperglycemia. Enteric neurons are sensitive to glucose, and 
hyperglycemia can induce apoptotic pathways. Furthermore, decreased neuronal 
growth factors, free fatty acids in the circulation as well as oxidative stress are all 
contributing factors to the neuronal damage. (145, 149) 
The ICCs are known as the pacemaker cells of the stomach and have important 
functions in the neurotransmission between smooth muscle cells in the GI wall, 
efferents from the CNS and enteric motor neurons (145). Depletion of ICCs in the 
stomach is strongly associated with gastroparesis (150, 151). Injury of ICCs is not 
only mediated through hyperglycemia, but probably through immune dysregulation 
driven by macrophages and oxidative stress (Fig. 6, courtesy of Grover et al). 
Furthermore, impaired insulin and insulin growth factor production (IGF-1) can cause 
damage to ICCs and myenteric cholinergic neurons (152). 
 
Small bowel dysmotility 
In a study using Wireless Motility Capsule (WMC), Barshop and co-workers found a 
negative correlation between duodenal motility and upper gastrointestinal symptoms 
(153). This suggests that the duodenum is involved in symptom generation in diabetic 
gastroparesis as well, as previously mentioned for functional dyspepsia. Cogliandro et 
al. found that enteric dysmotility was a more common finding in patients with 
classical gastroparesis symptoms than delayed gastric emptying, and that enteric 
dysmotility correlated with the degree of upper GI symptoms (154). The WMC 
enables investigation of the otherwise inaccessible small bowels non-invasively and 
is a promising tool for future studies (150). 
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2.6 Gut-brain interactions 
According to the Rome IV criteria of 2016, functional dyspepsia and irritable bowel 
syndrome are defined as “Disorders of gut-brain interactions” (155). The Gut-brain 
axis is the term defining the connections between the gastrointestinal tract, the 
myenteric plexus, and the central nervous system. This bidirectional model explains 
how psychosocial factors can affect gastric and intestinal function, and how factors in 
the gut can modulate sensory input.  
Visceral hypersensitivity 
Abdominal pain is a key symptom in IBS and functional dyspepsia, although routine 
examinations such as endoscopies show normal results. An important explanation for 
the reported pain is visceral hypersensitivity, where mechanical or chemical stimuli 
such as the regular stretching of the bowel wall during peristalsis is perceived as pain. 
The degree of visceral hypersensitivity is correlated to the GI symptom severity in 
both IBS and FD (108). The mechanisms of visceral hypersensitivity are complex, 
probably involving neurogenic, microbial, and immunological factors. There are 
evidence for a crosstalk between bacteria in the gut lumen and the nervous system 
leading to pain sensitization, and a disruption of communication between immune 
cells, neurons and non-neuronal cells can result in visceral hypersensitivity (156). 
Psychological factors and emotions 
Emotions such as anger, anxiety and stress can affect several aspects of gastric and 
intestinal function, resulting in increased acid secretion, delayed gastric emptying and 
antral motility and impaired accommodation (27, 157, 158). Furthermore, input from 
the brain can delay intestinal motility, decrease colonic transit, induce defecation, and 
give symptoms of diarrhoea. At the same time, intestinal inflammation, altered 
motility and tissue damage can affect the perception of pain (159), and result in 
altered mental function, including depression and anxiety. The anterior cingulate 
cortex is a brain region involved in emotional arousal and salience network and is 
vulnerable for changes in the gut (155). Larsson et al. demonstrated that not all 
patients with IBS reacted strongly to rectal balloon distention. They found that the 
patients could be divided into two groups (normo-sensitive and hypersensitive) based 
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on their response to this stimuli, and found differences in brain response between the 
two groups (160).  
Anxiety and depression are frequent conditions in the general population and are 
recognized comorbidities for many patients with functional gastrointestinal diseases. 
For this reason, functional GI diseases has by some authors been regarded as 
psychosomatic disorders. However, more recent knowledge has challenged this view. 
Results from separate prospective studies points toward a bidirectional trend; GI 
symptoms arose first and mood disorders later in at least half of the cases (161, 162). 
This illustrates the complexity of the connections between the mind and the gut; in 
some cases the anxiety or depression might have been the primary symptom, and 
should be emphasized in treatment, while other patients had gastrointestinal 
symptoms at first, and anxiety/depression developed subsequently. This is supported 
in a review by Koloski, Holtmann and Talley. They argue that some patients have 
primarily psychological disorders resulting in secondary FGID problems (“brain-
gut”), while another subset of patients have primarily gastrointestinal problems and 
secondary psychological symptoms (“gut-brain”) (70). 
 
Gut-Brain interactions in diabetes   
Interactions between the gastrointestinal tract and its microbes, and the brain, is 
possibly of importance in many conditions, not only the functional gastrointestinal 
disorders. There are evidence of changes of functional and structural brain patterns in 
diabetes, in particular in the insula region (163). Two meta-analyses demonstrated 
that depression was more common in patients with type 2 diabetes compared to the 
general population (164). Results from the Spanish ZARADEMP project suggested a 
bidirectionality in the association between diabetes and depression. In a 5 year 
prospective study, Campayo et al. found an 65% increased risk of type 2 diabetes in 
patients with clinically significant depression (165). Suffering from type 2 diabetes 
was associated with an increased risk of prevalent depression and incident depression 
(166).  
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Diabetes is associated with changes in the microbiome, and with affection of 
microbiome-gut-brain interactions (167, 168). The gut microbiota can influence 
glucose metabolism, and changes in the microbial composition are associated with 
obesity, metabolic syndrome, prediabetes and type 2 diabetes (169-171). Diabetes 
may exhibit low-grade inflammation, in which damaged and necrotic adipocytes 
release tumour necrosis factor alpha (172, 173). This is still a field of research, where 
much remains unknown, but there seems to be a link between the observed 
inflammation and the gut microbiota (172). 
 
The role of the vagus nerve in IBS, functional dyspepsia and diabetic gastroparesis 
The vagus nerve plays a pivotal role in the communication between the 
gastrointestinal tract and the brain, and the communication is bidirectional. The vagus 
nerve is composed of 80% afferent and 20% efferent nerve fibres and is involved in 
motility (i.e. gastric accommodation and gastric emptying), sensation, and is even 
involved in dampening peripheral inflammation via a cholinergic anti-inflammatory 
pathway. The vagus nerve is affected in both FD, IBS, and diabetic gastroparesis. 
Autonomic dysfunction is a well-known mechanism in diabetic gastroparesis, 
influencing gut transit time and gastrointestinal motility (45, 174). The functional 
gastrointestinal disorders are associated with autonomic disturbances of the vagus 
nerve (43, 97, 175, 176), with high sympathetic activation and low parasympathetic 
activation (177).  
Afferent fibres of the vagus nerve relay sensory information from the gastrointestinal 
tract, and are stimulated by mechanical, osmotic, and chemical stimuli. The vagal 
fibres from the stomach are stimulated by stretch and tension (178), and the signals 
are closely connected to the sensation of fullness and satiation. In a murine model, Li 
and co-workers found that chronic stress increased the response to distention in 
tension-sensitive gastric vagal afferent fibres, resulting in a lower food intake in 
exposed rats (179). Their findings implied that gastric vagal afferents were of 
particular importance for the symptoms of early satiety and postprandial fullness as 
reported in functional dyspepsia. Pellisier et al. found that patients with IBS had a 
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disrupted relationship between vagal tone and cortisol levels, and further that patients 
with low vagal tone had high levels of norepinephrine and epinephrine in plasma. 
This is a sign of activation of the sympathetic nervous system and a stress response. 
They suggested that hypo-activation of the prefrontal cortex and hyperactivity of the 
amygdala can explain the vulnerability for stress commonly observed in IBS patients 
(180, 181). Frøkjær and co-workers investigated the role of the vagus nerve further 
by stimulating the auricular branch of the vagus nerve in healthy subjects by 
transcutaneous electrical vagal nerve stimulation and deep slow breathing. They 
found that vagal modulation resulted in enhanced gastric motility and reduced 
somatic sensitivity (182).  
Diabetic gastroparesis is associated with visceral hyposensitivity as well as 
hypersensitivity (183). In a study on 20 diabetes patients with symptoms of 
gastroparesis Søfteland and co-workers examined rectal sensitivity and compared the 
results to gastric emptying. They found that diabetes was associated with reduced 
rectal sensitivity compared to healthy controls (184). In a meta-analysis and 
systematic review from 2019, Vijayvargiya and co-workers found that upper 
gastrointestinal symptoms correlated well to gastric emptying tests. However, the 





The literature review was concluded at March 10th, 2021. 
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3. Aims and hypothesis 
3.1 Hypotheses:  
Main hypothesis: There are similarities in gastric motility and 
sensitivity in functional dyspepsia, irritable bowel syndrome and 
diabetic gastroparesis. 
H1:  Patients with diabetic gastroparesis and functional dyspepsia are similar 
regarding gastric accommodation and sensitivity. 
H2:  Patients with IBS have disturbed gastric motility and visceral hypersensitivity 
of the upper GI tract. 
H3:  Patients with overlapping IBS and FD differ from patients with only IBS or 
FD, indicating affection throughout the gastrointestinal tract.   
H4:  The ultrasound meal accommodation test can identify patients with delayed 
gastric emptying. 
3.2 Aims  
The objective of this dissertation was to investigate the link between 
gastric motility disturbances such as delayed gastric emptying and 
impaired accommodation, and symptoms from the upper 
gastrointestinal tract. 
Aim of paper 1: To investigate how the ultrasound meal accommodation test for 
dyspepsia can been used in the clinic, and to identify patient groups in need for 
further investigation. 
 
Aim of paper 2: To elucidate gastric motility in IBS, and to compare UMAT results 
from IBS patients with patients with functional dyspepsia or overlapping IBS/FD. 
 
Aim of paper 3: To explore the relationship between the proximal and distal stomach 
in patients with diabetic gastroparesis, and to investigate the association between 
gastric motility parameters and upper GI symptoms.   
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4. Materials and Methods 
4.1 Study population 
4.1.1 Healthy controls 
Healthy controls (HC) were recruited among colleagues using e-mail and bulletin 
boards at Haukeland University Hospital, and among nursing students at the 
University College of Western Norway. All participants received written and oral 
information about the study and signed consent before inclusion. All data about the 
participants have been stored anonymously at a secure server and in locked cabinets 
only available for the PhD student. Inclusion and exclusion criteria are presented in 
Table 4. 
Table 4: Inclusion and exclusion criteria for the healthy controls study. 
Inclusion criteria Exclusion criteria 
 Age 16-65 years  Use of medication known to affect 
gastric motility 
 Healthy individuals  Functional GI disorders, diabetes, or 
chronic GI diseases 
 BMI <30  Previous abdominal surgery, except 
section or appendectomy 
 Speak and read Norwegian 
language 
 Chronic fatigue syndrome (CFS/ME) 
  Allergies to ingredients in the meat soup 
  Confirmed pregnancy 
As most patients with functional gastrointestinal disorders are women, we included 
more women (66%) than men.  
4.1.2 Participants in Papers 1 and 2 
The Ultrasound Meal Accommodation test (UMAT) has been used clinically at 
Haukeland University Hospital for 25 years. Patient reports from the last 15 years 
(1999-2014) were identified (n=509). As reported in paper 1, in 8 cases it was not 
possible to complete the UMAT procedure for different reasons, and 75 patients were 
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not able to complete the 500 mL drink test. Information was collected from 
questionnaires, as well as the electronic patient records, and recorded systematically 
in an anonymous database (FileMaker Pro). Findings from this database is described 
in detail in Paper 1.  
Patients with irritable bowel syndrome (n=88), functional dyspepsia (n=94) or 
overlapping IBS and FD (n=66) were included in the data material for paper 2. Figure 
7 shows an overview. 
 
Figure 7: Overview of the included patients in paper 1 and 2, from the 
ultrasound meal accommodation test database.  
 
4.1.3 DIAGAS – Diabetic gastroparesis  
Patients referred to the Department of Medicine at Haukeland University Hospital 
with symptoms of gastroparesis were included in a prospective study (DIAGAS 
study). They were examined with scintigraphy, Wireless motility capsule and the 
ultrasound meal accommodation test, as well as clinical examination, blood samples 
and autonomic tests. Patients with diabetes as well as other etiologies were included.  
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In Paper 3, we have included all patients with diabetes who were examined with the 
UMAT (n=58). Due to practical challenges, not all patients were able to do this. In 
Figure 8 we present the DIAGAS study.  
 
Figure 8: Overview of the patients in the DIAGAS study, and the included 
patients in paper 3. 
4.2 The ultrasound meal accommodation test 
The protocol for the ultrasound meal accommodation test (UMAT) used in this thesis 
has been described in Gilja et al. (185). Using a low-caloric commercial meat soup 
(Toro klar kjøttsuppe, Orkla, Norway. Contents: 84 kJ; 1.8 g protein, 1.1 g 
carbohydrate, 0.9 g bovine fat) as a test meal, the proximal and distal stomach can be 
visualized by ultrasound.  
We have used different labels for the proximal measurements in paper 2 and paper 3. 
For clarity, “Oblique frontal diameter” in paper 2 is the same measurement as 
“Proximal diameter” in paper 3, and “Sagittal area” in paper 2 is the same 
measurement as “Proximal area” in paper 3.  
For further details about the ultrasound meal accommodation test we refer to the 
included papers.  
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4.3 Gastric emptying scintigraphy 
The patients included in study 3 were examined with gastric emptying scintigraphy 
the day after the ultrasound meal accommodation test. Thus, gastric emptying rate 
was not known to the examiner at the time of the ultrasound test. 
The protocol for gastric emptying scintigraphy is described in paper 3 and by 
Sangnes et al (186). A gastric content retention >10% after 4h was considered 
pathological, and was used to define gastroparesis in our study (187). 
 
4.4 Questionnaires  
4.4.1 Diagnostic questionnaires  
In paper 1, we present results from the Rome II and Rome III questionnaires, 
translated to Norwegian by Vandvik (188) and Lied, respectively. More details about 
the Rome criteria during the study period are presented in the Background section of 
this thesis. 
 
4.4.2 Psychometric questionnaires 
Traits of neuroticism were measured using the 12 item questionnaire from Eysenck 
(Eysenck’s Personality Questionnaire-neuroticism (EPQ-N); Revised, Short form) 
(189). Gastrointestinal specific anxiety was measured with the Visceral Sensitivity 
Index (VSI), a questionnaire proven to be useful in populations with FGIDs (190, 
191).  
 
4.4.3 Symptom registration and symptom load 
To evaluate symptom severity of IBS-related symptoms, we used the IBS Symptom 
severity Score (IBS-SSS). The maximum possible score is 500, and values <75 are 
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considered normal. Cases scoring 75-150 are considered mild, 150-300 moderate, and 
>300 severe (192). 
Visual analogue scales (VAS) has proven valuable to record nausea and is recognized 
as a good method of evaluating symptoms in diagnoses such as gastroparesis (193). 
In all three papers of this project, we have measured nausea, epigastric pain, 
fullness/bloating, satiety, and upper abdominal discomfort on a VAS ranging from 0-
100 mm. The measurements have been reported in a fasting state, and simultaneously 
with all ultrasound measurements; at 1, 10 and 20 minutes postprandially. In paper 1, 
we have analyzed fasting symptoms as well as the change in symptoms after drinking 
soup. In paper 2, we have compared fasting symptoms between groups, as well as 
immediate postprandial symptoms between groups, and investigated the correlations 
between symptoms and ultrasound measurements as well as psychometric scores. We 
did not have complete registrations on symptoms 10 and 20 minutes postprandially, 
as only one of the two physicians performing the test asked for symptom registration 
at these time points. In paper 3, we have included symptoms in a fasting state as well 
as at 1, 10 and 20 minutes and incorporated these measures to a linear mixed effects 
model together with ultrasound measurements and group belonging.  
 
4.5 Methodological considerations and study limitations 
4.5.1 Study design 
Studies 1 and 2 were designed as retrospective cross-sectional observation studies on 
a clinical material. Ultrasound measurements and symptom registration, as well as 
some questionnaires, were systematically collected throughout the period of 
registration, and some information was registered systematically in the patient 
records of all patients. Examples are the final diagnosis after the UMAT in cases 
where a conclusion was drawn, or information of relevant co-morbidity such as 
diabetes or Parkinson’s disease. Information about anxiety and depression was often 
reported, but this information is less certain. Unfortunately, we do not have 
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information about subclassification of the IBS or functional dyspepsia diagnoses 
(constipation/diarrhoea dominated IBS, postprandial distress syndrome or epigastric 
pain syndrome) on all patients. This information would certainly be useful to have in 
our analyses. 
Study 3 was designed as a prospective, cross-sectional open observational study. The 
ultrasound was performed before the scintigraphy procedure, and thus the physicians 
were blinded for the outcome of the scintigraphy results (gastroparesis/not 
gastroparesis).  
Causality and associations 
A cross-sectional observation study does not provide evidence for causality or risk, 
but it allows us to investigate associations and correlations. The findings must 
however always be interpreted with care, as the real association may be to a third 
factor that may not be identified (confounding factor) (194, 195).  
 
4.5.2 Study populations 
The study population from studies 1 and 2 were patients referred to a tertiary 
specialist clinic because of abdominal complaints. As presented in paper 1, 51% of 
the patients were referred as second opinion patients from other hospitals or 
specialists, and 40% came from other counties than Hordaland county where 
Haukeland University Hospital is situated. This implicates that the patient population 
may not be representative for the average IBS or FD patient in society, but rather the 
patients we normally see at a specialist outpatient clinic at a University clinic. The 
retrospective design reduces however the selection bias often observed in prospective 
clinical studies, as almost all patients examined with this test were included in the 
study. Groups that may not be well represented are patients with language difficulties, 
who could not answer the Norwegian questionnaires, or patients with intellectual 
disability. We recognize that is important to study these groups as well, and it is 
unfortunate that they are not represented in our study. Furthermore, we have only 
investigated individuals aged >18 years. 
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In study 3, all patients referred to a clinical examination with question of diabetic 
gastroparesis were prospectively included. They were given the opportunity to 
receive the same medical care and examinations without participating in the study, 
but all chose to be included. This design limits selection bias. The patients are not 
representative for the general population of diabetes patients, but we believe they are 
representative for patients with suspected gastroparesis.  
 
4.5.3 Ultrasound 
Ultrasound is user-dependent, but the reproducibility of the measurements included in 
the ultrasound meal accommodation test has been investigated in several studies. 
Hveem et al. evaluated the intraobserver and interobserver variance of antral area 
measurements and found an overall coefficient of variance 6% (196). Furthermore, 
Gilja et al. studied the variance of ultrasound measurements of the proximal stomach 
(39) and found correlations of 0.95 and 0.94 for proximal area and proximal diameter 
between two examiners.  
The UMAT is a well-established examination at Haukeland University Hospital, and 
the examinations included in Papers 1 and 2 were performed by two 
gastroenterologists with long experience in abdominal ultrasound (OHG and TH). 
Both doctors did their PhD on gastric ultrasound years before 1999, when the first 
patient was included in the retrospective study. In difficult or unclear cases, they 
consulted with each other. The ultrasound examinations in paper 3 were performed 
by TH and the PhD candidate (EKS). EKS had at the time 2-4 years of training in the 
procedure, having performed over 50 UMAT before the healthy controls study and 
DIAGAS study. She consulted with TH or OHG for most examinations.  
 
Comparing ultrasound measurements to scintigraphy results 
In paper 3, we have investigated the results of the ultrasound meal accommodation 
test to results from gastric emptying scintigraphy (GES). In GES we evaluate gastric 
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emptying by a solid meal and have used the gold standard measurement of gastric 
retention at 4h (%). As demonstrated in Figure 9, gastric emptying is markedly 
different for a low-calorie drink compared to a calorie-containing solid meal (12) and 
doing head-to-head comparisons would not be meaningful. We wanted to investigate 
if patients with gastroparesis differed from the ones with normal gastric emptying, 
and thus used the 4h scintigraphy value as a reference value.  
 
Figure 9: The physical characteristic and caloric density of food affect the 
gastric emptying rate. (A) Gastric emptying of food of different physical 
characteristics (B) The caloric density of a liquid meal is an important factor 
in gastric emptying. The low-calorie soup used in the UMAT protocol is 
estimated to empty similarly to the “Low-calorie liquids” in graph B. Printed 
with permission from John Wiley and Sons (12). 
  
4.6 Statistical methods 
4.6.1 Paper 1 
The variables included in paper 1 were generally not normally distributed, and we 
used non-parametric tests to analyse differences between groups. Incidence between 
groups were compared using Chi-square. 
4.6.2 Paper 2 
This paper was written later than Paper 1, and because of new knowledge (for the 
candidate) after several courses in medical statistics, other considerations were done 
concerning the choice of tests. Due to the Central Limit Theorem, one can assume 
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normality of the number of observations is high enough. This was the case in study 2, 
and we chose to analyse the data using parametric tests. To analyse two continuous 
variables in independent groups, we used Student’s t-test. When comparing more 
than two groups, we used one-way ANOVA or Welch’s ANOVA depending on 
results from Levene’s test. In the cases where the variance was different between the 
groups, we used Welch’s ANOVA. The sample size was different between healthy 
controls and patients, and for this reason we used the Games-Howell post-hoc test. 
Association were analysed using Linear regression, Pearson’s correlation, and logistic 
regression, and we presented the results with odds ratio (OR) with 95% confidence 
intervals (CI).  
 
4.6.3 Paper 3 
In the work with Paper 3, we observed that the ultrasound measurements of patients 
with delayed gastric emptying followed a different pattern compared to patients with 
normal gastric emptying. To further investigate this phenomenon, we contacted a 
statistician at our hospital (Jürg Assmus), who suggested using a Linear Mixed 
Effects (LME) model to investigate how the ultrasound measurements of the stomach 
was influenced by time, group belonging (based on gastric emptying) and an 
intercept. Furthermore, we applied an LME model to study the effect on symptoms. 
An advantage of the LME model is that it enables us to study the effect of time on our 
measurements. The model adjusts for a random distribution in the population 
(intercept). Furthermore, the ultrasound and symptom measurements were not 
independent of each other. Independent observations are required in tests such as one-
way ANOVA or regular regression analyses.  
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4.7 Ethical considerations and approvals 
The retrospective study in paper 1 and 2 was defined as a quality control project and 
did not need approval from the Regional Ethical Committee. The study was approved 
by the Data Protection Official at Haukeland University Hospital (2014/20478). The 
healthy controls were prospectively included in a project approved by the Regional 
Ethical Committee of South-Eastern Norway (2014/222-20). 
The prospective DIAGAS study was approved by the Western Norway Regional 
Ethical Committee (REK 2015/58). 
All data were anonymously stored in secure servers according to guidelines. 
Participants in Study 3 and healthy controls signed informed consent and were able to 
withdraw consent at any time up to publication. Studies were performed in 
accordance with the Helsinki declaration.  
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5. Results and summary of the papers 
5.1 Paper 1 
This paper provides an overview of the 509 patients examined with the Ultrasound 
Meal Accommodation test (UMAT) during 1999-2014. We found that 49% of the 
referred patients were diagnosed with functional dyspepsia (FD) and/or irritable 
bowel syndrome (IBS). Patients with FD reported a marked increase in symptoms 
induced by the 500 mL meal. Patients with overlapping IBS and FD reported higher 
increase in upper abdominal discomfort. In FD patients, 36 % were found to have 
impaired accommodation, 31% had delayed gastric emptying and 20% had visceral 
hypersensitivity. Patients with diabetes in this material differed from FD patients with 
lower symptom increase after soup intake.  
5.2 Paper 2 
In this paper, we included the 248 patients with IBS and/or FD from the material 
from paper 1. We prospectively recruited 30 healthy controls to compare ultrasound 
measurements and symptoms. We found that patients in all groups reported higher 
symptoms of nausea, discomfort, epigastric pain, and fullness/bloating in both fasting 
and postprandial state compared to healthy controls. Functional dyspepsia patients 
had lower proximal stomach measurements, a sign of impaired accommodation, but 
patients with IBS had normal accommodation. Both IBS and FD patients had 
enlarged antral measurements in a fasting state.  
Patients who did not complete the 500 mL meal were more likely to be female (OR 
5.14 (95% CI: 1.20, 22.40)) and to be diagnosed with functional dyspepsia (OR 
3.67(95% CI: 1.29, 10.41)).  
Nausea was not correlated to neuroticism or gastro-specific anxiety (VSI) and was 
highest in patients with functional dyspepsia.  
 
 55 
5.3 Paper 3 
In this paper, we examined 58 patients with diabetes and symptoms of gastroparesis 
with gastric emptying scintigraphy of a solid meal, and ultrasound of the proximal 
and distal stomach after a liquid meal. By using a linear mixed effects model we 
found that gastroparesis patients (diagnosed by scintigraphy) had a slower decrease in 
proximal stomach size during 20 minutes after the liquid meal compared to healthy 
controls (P<0.01), and proximal stomach size at 20 minutes was correlated to 
scintigraphy (r=0.510, P=0.001). Furthermore, the gastroparesis patients had over 
twice as large antral area in a fasting state compared to healthy controls, and higher 
postprandial measurements of the antrum. The antral area was modestly associated 
with results of the scintigraphy (r=0.329, P=0.013). Patients both with and without 
gastroparesis had impaired accommodation after a liquid meal. The patients in both 
groups reported higher levels of upper GI symptoms in a fasting and postprandial 
state compared to healthy controls. There was no difference in symptom load 





Our primary hypothesis was that similarities in gastric motility and sensitivity in FD, 
IBS, and diabetic gastroparesis exist. To investigate this hypothesis, we evaluated the 
results of the ultrasound meal accommodation test in 248 patients with IBS and/or 
FD, and in 58 patients with diabetes and symptoms of gastroparesis.  
 
6.1.1 Gastric emptying  
Delayed gastric emptying is a fundamental requirement for the gastroparesis-
diagnosis, and although the gold standard is scintigraphy, the antral area as measured 
by ultrasound demonstrated good agreement with gastric volume and emptying (54).   
In paper 3, we found that patients with gastroparesis had significantly larger antral 
area both fasting and postprandially, and we found a modest correlation between 
scintigraphy measurements 4 h after a solid meal and fasting antral area. Patients with 
functional dyspepsia and/or irritable bowel syndrome exhibited enlarged antral area 
in fasting state compared to healthy controls (Paper 2), but the antral measurements 
were not as large as in the gastroparesis-group. It is well-known that some patients 
with functional dyspepsia have delayed gastric emptying (197). Furthermore, irritable 
bowel syndrome is associated with delayed gastric emptying (198-200), indicating a 
pan-enteric motility disturbance in a subgroup of patients. To our knowledge, not 
many reports have been published on gastric motility in the IBS+FD group. Futagami 
et al. found delayed gastric emptying in the IBS+FD group compared to healthy 
controls, and found that the gastric emptying in this group was similar to findings 
from the other FGID groups investigated (201). This is well in accordance with our 
findings.  
A cross-sectional area of the antrum is considered the best choice for 
ultrasonographic assessment of gastric emptying. In paper 3, we found a weaker 
association between antral area and scintigraphy than we had expected. However, 
surprisingly we found stronger correlation between proximal ultrasound 
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measurements at 20 min and scintigraphy. Furthermore, the results from the linear 
mixed effects model showed a slower decrease of the proximal stomach size in 
gastroparesis patients. Lately, other groups have studied the role of the proximal 
stomach in gastric emptying. Orthey et al. demonstrated that an enhanced gastric 
emptying scintigraphy protocol could be used to assess the gastric emptying rate of 
the proximal stomach in healthy subjects (202). Edholm et al. used scintigraphy to 
study gastric emptying, and studied the effects of incretin hormones on the proximal 
and distal part of the stomach during gastric emptying (203). This supports our 
ultrasound results indicating that the proximal stomach is of importance in the gastric 
emptying process in diabetic gastroparesis.  
 
6.1.2 Accommodation of the proximal stomach 
We found that patients with functional dyspepsia and diabetic gastroparesis had lower 
measurements on ultrasound of the proximal stomach at 1 and 10 minutes 
postprandially compared to healthy controls. This implies impaired accommodation, 
as demonstrated by Gilja et al on a population of functional dyspepsia patients, and 
Undeland et al. on a population of diabetes patients (39-41, 45). Thus, our findings 
are well in agreement with previous research. Impaired accommodation is a common 
finding in studies of functional dyspepsia as well as diabetic gastroparesis (183, 204).  
Furthermore, we investigated the gastric accommodation in patients with irritable 
bowel syndrome and found that the postprandial proximal stomach in IBS patients, 
and in patients with overlapping IBS and FD, was not different from healthy controls. 
This indicates normal gastric accommodation in these groups. Gastric 
accommodation in patients with IBS has, to our knowledge, not been studied. In one 
study by Masny et al. on 20 patients with IBS and 20 healthy controls, the effects of 
an intragastric infusion of fructans vs glucose was assessed with manometry. They 
found no difference in the gastric accommodation between healthy and IBS (205). 
This is in keeping with our results from paper 2. Accordingly, our finding shows that 
patients with IBS are different from FD with respect to gastric accommodation. 
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6.1.3 Relationship between symptoms and motility, and visceral 
hypersensitivity 
In this thesis, we found that patients with diabetic gastroparesis, functional dyspepsia 
and irritable bowel syndrome all reported higher postprandial upper GI symptoms 
compared to healthy controls. We have found some weak correlations between 
ultrasound measurements and symptoms, but no single mechanism or measurement 
can explain all findings. However, this was as expected. A common denominator for 
these conditions is that they are multifactorial in origin. 
In paper 3, we found a negative association between epigastric pain/discomfort and 
the ultrasound measurements in the non-gastroparesis group. The association to the 
proximal stomach implies a relationship between delayed impaired accommodation 
and pain/discomfort. In the gastroparesis group, we found no associations between 
symptoms and ultrasound measurements. A possible explanation may be that some 
patients with gastroparesis develop hyposensitivity, causing a large variance in the 
reported symptoms. This is supported by studies by Søfteland and Brock who found 
that diabetes patients with severe gastrointestinal symptoms had lower sensitivity to 
painful stimuli (184, 206). 
In paper 2, we found only a weak correlation between postprandial nausea and 
proximal diameter 20 min after the meal, in patients with IBS and/or FD. Our 
findings suggest that although impaired accommodation and antral distention are 
common findings in FD and IBS, they do not explain all the patients’ symptoms. 
Possibly, visceral hypersensitivity is a more important factor for postprandial 
symptoms in these groups. This is particularly evident in the overlap group of 
IBS+FD. In this group, we found normal accommodation, but higher symptom scores 
compared to the other groups. We believe that this group is of particular interest for 
studying visceral hypersensitivity in later studies. This is in agreement with previous 
findings from several different groups. Choi et al. analyzed symptoms and 
overlapping diagnoses in a Korean out-patient Gastroenterology clinic, and found that 
IBS+FD patients had more severe symptoms and higher depression scores compared 
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to patients with only one FGID (207). In a study on FGID patients from an out-
patient clinic in Australia, Von Wulffen et al. found that the IBS+FD patients 
reported higher symptom load compared to other groups (208).  
The patients with IBS reported higher levels of nausea, epigastric pain and discomfort 
compared to healthy controls both fasting and postprandially. This observation is 
consistent with findings from other groups (198, 199). Slightly delayed gastric 
emptying and normal accommodation and marked upper GI symptom load in this 
patient group indicates that visceral hypersensitivity may be an important contributor 
to this patient group’s symptoms. A strong association between GI symptoms and 
visceral hypersensitivity in a multicenter study on FD and IBS (108) strengthens this 
hypothesis.  
As both gastric emptying and accommodation are depending on stimuli from efferent 
nerve fibers of the vagus nerve (209, 210), damage to or dysfunction of the vagus 
nerve is a possible explanation of both dysmotility and altered sensation in diabetic 
gastroparesis and functional gastrointestinal disorders. 
 
6.1.4 Strengths and limitations 
One of the main strength of this work is the large number of patients included, 
particularly in papers 1 and 2. Furthermore, the patients were included consecutively 
from the ordinary outpatient-clinic at our hospital and not specifically recruited to a 
clinical study, reducing recruitment bias. We believe the patients included in the 
studies are representative for the patients we meet on a daily basis at our University 
clinic. 
Limitations are discussed in each paper, but worth mentioning is that the healthy 
controls group was not age-matched for the diabetes patients. Furthermore, we lacked 
consistent information about subtype of IBS and FD. Papers 1 and 2 were based on a 
retrospective clinical material. The use of different questionnaires and diagnostic 
criteria changed over the years, resulting in missing data. And finally, in paper 3, we 
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compared gastric emptying of a solid meal to a low-caloric liquid meal, as discussed 




We have demonstrated that functional dyspepsia, irritable bowel syndrome and 
diabetic gastroparesis are conditions with many overlapping symptoms. A hallmark 
symptom in both FD and gastroparesis is postprandial fullness and epigastric 
discomfort, and we have shown that nausea is very common in all three conditions.  
We found that gastric motor function in the three conditions have many similarities. 
First, we found impaired accommodation in both functional dyspepsia and diabetic 
gastroparesis, likely because of affection of vagal efferent fibers. Second, we found 
that the antrum was enlarged in diabetic gastroparesis, as well as in IBS and FD– 
although less pronounced. Third, we found that the proximal stomach in diabetic 
gastroparesis had a reduced gastric emptying rate. This illustrates the importance of 
assessing both proximal and distal part of the stomach when examining patients with 
suspected gastroparesis. 
The gastric motor function was only weakly correlated to upper GI symptoms in 
functional dyspepsia and IBS, and visceral hypersensitivity may explain some of the 
symptoms these patients report.  
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8. Future perspectives 
8.1 Clinical implications 
During the work with this thesis, we have established normal values for the 
ultrasound meal accommodation test. This may be of value for everyday clinical 
work and will make it easier to implement the procedure in other clinics. We have 
shown that symptoms alone cannot discern between gastroparesis or no gastroparesis, 
but an enlarged antral area on ultrasound is a strong indication for further work-up. 
 
8.2 Implications for further research 
It is evident that impaired accommodation and delayed gastric emptying cannot 
explain all symptoms reported by patients with diabetic gastroparesis and functional 
dyspepsia. However, in recent years, several studies have found evidence for a 
pivotal role for the duodenum, as well as the gut microbiota. We suggest 
investigating this further in large studies with different modalities. Heterogeneous 
conditions with multifactorial genesis call for advanced computational analysis, such 
as machine learning models. Gastrointestinal and extraintestinal symptoms, motility 
parameters, psychological factors, microbiota composition and short chain fatty acids, 
as well as measures of brain activity should all be analyzed together in the search for 
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